Skip to main content
. 2016 Feb 25;24(5):326–331. doi: 10.1007/s12471-016-0805-y

Table 1.

Baseline characteristics

Total (n = 69) Clinical HCM (n = 55) Subclinical HCM mutation carriers (n = 14)
Age (years) 51 ± 16 54 ± 16 40 ± 10
Male 38 (55) 34 (62) 4 (29)
Pathogenic mutation present 37 (54) 23 (42) 14 (100)
NYHA class I/II 67 (97) 53 (96) 14 (100)
NYHA class III 2 (3) 2 (4)

Data are presented as mean ± standard deviation or numbers (percentages). HCM hypertrophic cardiomyopathy, NYHA New York Heart Association.